Registry confirms nintedanib efficacy under real-life conditions Presented ByProf. Jürgen Behr, Ludwig-Maximilian-University Munich, Germany TrialINSIGHTS-IPF ConferenceERS 2019 TypePeer-reviewed article 28 November 2019 16:15